LA JOLLA, Calif. — You could easily mistake it for a big CD rack. Inside the lab at the California Institute of Biomedical Research, known as Calibr, sits a stacked array of several dozen plastic ...
In March 2012, the California Institute for Biomedical Research (Calibr), a nonprofit devoted to translating basic science into drug candidates, launched amid much fanfare. Fueling the hype was an ...
AbbVie to maintain exclusive access to Calibr-Skaggs' switchable CAR-T (sCAR-T) platform to develop novel cell therapy candidates against solid tumor targets identified by AbbVie AbbVie also has the ...
CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, ...
AbbVie , a research-based global biopharmaceutical company, and Calibr, a nonprofit drug discovery division of Scripps Research, today announced a collaboration to develop T-cell therapies aimed ...
California biotech Calibr and research partner AbbVie have clearance to start clinical trials of a new CAR-T technology, involving “switchable” cells that aim to eliminate the life-threatening ...
LA JOLLA, CA— Calibr, a division of Scripps Research focused on the “bench to bedside” development of transformative medicines, today announced encouraging preliminary data from the first nine ...
No articles found. California Institute for Biomedical Research (Calibr), Scripps Research did not contribute to any primary research papers from Nature Index journals in the current 12 month window.
Identifying peptides and proteins from mass spectrometry (MS) data, spectral library searching has emerged as a complementary approach to the conventional database searching. However, for the spectrum ...
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) ...
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) ...
(RTTNews) - The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, said that AbbVie (ABBV) has expanded its collaboration to further explore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results